Long COVID Immune Profiling

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 24, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2026

Conditions
Long COVIDPOTS - Postural Orthostatic Tachycardia SyndromeAutonomic Dysfunction
Interventions
DIAGNOSTIC_TEST

IL-6

"Compare IL-6 level , as a marker of inflammation in all the 3 groups:~* POTS patients~* post-COVID-19 POTS~* gender, age, and BMI-matched controls, with history of COVID-19 infection without sequelae."

DIAGNOSTIC_TEST

cytokines (IL-17, and IFN-ɣ)

"Compare Proinflammatory cells and its secreted cytokines (IL-17, and IFN-ɣ) in all the 3 groups:~* POTS patients~* post-COVID-19 POTS~* gender, age, and BMI-matched controls, with history of COVID-19 infection without sequelae"

BEHAVIORAL

Compass 31

Autonomic symptoms assessment questionnaire (COMPASS 31), in post-COVID-19 POTS and compare with POTS patients

Trial Locations (1)

37027

RECRUITING

Cyndya Shibao, Nashville

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

Vanderbilt University Medical Center

OTHER